Skip to main content

Table 4 Mismatch negativity (MMN) mean amplitudes and latencies

From: Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study

 TD (n = 35)TSC (n = 8)
Time pointD0D0D91D119
Deviant typeAmp (SD)Lat (SD)Amp (SD)Lat (SD)Amp (SD)Lat (SD)Amp (SD)Lat (SD)
Standard−1.82 (.92)255 (21)−1.45 (.46)253 (34)−1.51 (.52)261 (12)−1.65 (.74)258 (34)
Frequency1.68 (1.22)ab138 (40)3.03 (1.75)a137 (23)−2.75 (1.71)136 (28)−2.23 (.70)125 (28)
Duration−1.91 (1.31)193 (49)1.71 (1.5)c206 (28)3.11 (1.10)c206 (31)−1.92 (1.15)203 (20)
Freq/Dur−2.35 (1.15)130 (29)−2.28 (1.32)125 (34)−2.64 (1.52)116 (16)−2.46 (1.19)122 (25)
  1. Abbreviation: MMN mismatch negativity, Amp amplitude, Lat latency, SD standard deviation, Freq/Dur frequency duration deviant, TD typically developing control group
  2. aSignificant with Bonferroni correction; bgroup effect;ctreatment effect